Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Geller

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Scientific Reports|May 24, 2024
Functional antibody responses targeting the Spike protein of SARS-CoV-2 Omicron XBB.1.5 in elderly nursing home residents following Wuhan-Hu-1-based mRNA booster vaccinationÁngela Sánchez-Simarro, Daniel Fernández-Soto, Brayan Grau, et al.
Iscience|May 17, 2023
Assessment of SARS-CoV-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothersChristine Bäuerl, Joao Zulaica, Luciana Rusu, et al.
Journal of Medical Virology|June 23, 2025
Neutralizing Antibody and T-Cell Spike Targeted Responses Following Receipt of a Monovalent Omicron JN.1-Adapted mRNA COVID-19 Vaccine in Immunosuppressed and Healthy IndividualsÁngela Sánchez-Simarro, Diego Carretero, Brayan Grau, et al.
Journal of Medical Virology|November 25, 2020
Suitability of two rapid lateral flow immunochromatographic assays for predicting SARS-CoV-2 neutralizing activity of seraArantxa Valdivia, Ignacio Torres, Víctor Latorre, et al.
Blood Transfusion = Trasfusione Del Sangue|August 9, 2021
Preservation of anti-SARS-CoV-2 neutralising antibodies in convalescent plasma after pathogen reduction with methylene blue and visible lightLuis Larrea, Emma Castro, Laura Navarro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 22, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 VaccineEstela Giménez, Eliseo Albert, Joao Zulaica, et al.
Journal of Medical Virology|November 5, 2022
Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variantJorge Camacho, Estela Giménez, Eliseo Albert, et al.
Communications Biology|March 4, 2025
Synthetic heparan sulfate mimics based on chitosan derivatives show broad-spectrum antiviral activityJulia Revuelta, Luciana Rusu, Clara Frances-Gomez, et al.
ACS Omega|December 1, 2025
A Tetrapodal Tryptophan Derivative with Multiple Exposed Free Carboxylic Acids Blocks Host Cell Entry of Omicron SARS-Cov-2 and Respiratory Syncytial VirusOlaia Martí-Marí, Marta Moreno-Simoni, Ana Isabel Avilés-Alía, et al.
Mbio|November 16, 2021
Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2Paula Ruiz-Rodriguez, Clara Francés-Gómez, Álvaro Chiner-Oms, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Scientific Reports|May 24, 2024
Functional antibody responses targeting the Spike protein of SARS-CoV-2 Omicron XBB.1.5 in elderly nursing home residents following Wuhan-Hu-1-based mRNA booster vaccinationÁngela Sánchez-Simarro, Daniel Fernández-Soto, Brayan Grau, et al.
Iscience|May 17, 2023
Assessment of SARS-CoV-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothersChristine Bäuerl, Joao Zulaica, Luciana Rusu, et al.
Journal of Medical Virology|June 23, 2025
Neutralizing Antibody and T-Cell Spike Targeted Responses Following Receipt of a Monovalent Omicron JN.1-Adapted mRNA COVID-19 Vaccine in Immunosuppressed and Healthy IndividualsÁngela Sánchez-Simarro, Diego Carretero, Brayan Grau, et al.
Journal of Medical Virology|November 25, 2020
Suitability of two rapid lateral flow immunochromatographic assays for predicting SARS-CoV-2 neutralizing activity of seraArantxa Valdivia, Ignacio Torres, Víctor Latorre, et al.
Blood Transfusion = Trasfusione Del Sangue|August 9, 2021
Preservation of anti-SARS-CoV-2 neutralising antibodies in convalescent plasma after pathogen reduction with methylene blue and visible lightLuis Larrea, Emma Castro, Laura Navarro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 22, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 VaccineEstela Giménez, Eliseo Albert, Joao Zulaica, et al.
Journal of Medical Virology|November 5, 2022
Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variantJorge Camacho, Estela Giménez, Eliseo Albert, et al.
Communications Biology|March 4, 2025
Synthetic heparan sulfate mimics based on chitosan derivatives show broad-spectrum antiviral activityJulia Revuelta, Luciana Rusu, Clara Frances-Gomez, et al.
ACS Omega|December 1, 2025
A Tetrapodal Tryptophan Derivative with Multiple Exposed Free Carboxylic Acids Blocks Host Cell Entry of Omicron SARS-Cov-2 and Respiratory Syncytial VirusOlaia Martí-Marí, Marta Moreno-Simoni, Ana Isabel Avilés-Alía, et al.
Mbio|November 16, 2021
Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2Paula Ruiz-Rodriguez, Clara Francés-Gómez, Álvaro Chiner-Oms, et al.
Pageof 6